Efficacy of Varenicliner an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 296, n. 1, p. 56, doi. 10.1001/jama.296.1.56
- By:
- Publication type:
- Article